Company bioMérieux

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 16:55:00 10/02/2026 GMT			After hours 20:59:59
94.35 ^EUR	+1.07%		94.28	-0.08%

02-02	Oddo BHF Voices Concerns Over Currency Impact and Weaker Flu Season for bioMérieux
01-22	Interparfums, Michelin, Société Générale, Ubisoft... Stocks to Watch Today in Paris

Business description: bioMérieux

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows:

- medical applications (84.8%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors;

- industrial applications (15.2%).

The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services.

Net sales are distributed geographically as follows: Europe/Middle East/Africa (31.9%), North America (45%), Asia/Pacific (16,5%) and Latin America (6.6%).

Number of employees: 14,451

Sales by Activity: bioMérieux

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Clinical Applications	2.66B	2.88B	3.04B	3.1B	3.37B
Industrial Applications	455M	492M	549M	575M	606M

See all business segments

Geographical breakdown of sales: bioMérieux

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Americas	1.59B	1.67B	1.84B	1.85B	2.05B
Europe, The Middle East and Africa (EMEA) Excluding France	803M	902M	901M	-	1.03B
Asia-Pacific (ASPAC)	505M	580M	624M	638M	656M
France	219M	222M	220M	-	240M
Corporate	3.5M	3.3M	2.6M	900K	600K
Europe, The Middle East and Africa (EMEA)	-	-	-	1.19B	-

See all geographic segments

Executive Committee: bioMérieux

Manager	Title	Age	Since
Pierre Boulud CEO	Chief Executive Officer	54	30/06/2023
Guillaume Bouhours DFI	Director of Finance/CFO	49	28/02/2018
Charles Cooper CTO	Chief Tech/Sci/R&D Officer	-	01/01/2024
Jennifer Zinn CTO	Chief Tech/Sci/R&D Officer	-	31/07/2023
Valérie Leyldé HRO	Human Resources Officer	-	-

See BIOMÉRIEUX governance

Composition of the Board of Directors: bioMérieux

Director	Title	Age	Since
Jean-Luc Bélingard CHM	Chairman	76	31/12/2013
Alexandre Mérieux CHM	Chairman	52	14/12/2017
Philippe Archinard BRD	Director/Board Member	65	31/12/2004
Marie-Hélène Habert-Dassault BRD	Director/Board Member	60	29/05/2012
Harold Y. H. Boël BRD	Director/Board Member	61	29/05/2012
Fanny Letier BRD	Director/Board Member	46	29/06/2017
Marie-Paule Kieny BRD	Director/Board Member	70	27/08/2017
Sylvain Orenga BRD	Director/Board Member	-	23/05/2022
Benoît Ribadeau-Dumas BRD	Director/Board Member	54	-
Viviane Monges BRD	Director/Board Member	61	22/05/2024

Composition of the Board of Directors

Shareholders: bioMérieux

Name	Equities	%	Valuation
Compagnie Merieux Alliance SAS 58.9 %	69,720,270	58.9 %	8 112 M €
Dassault Family 3.002 %	3,553,520	3.002 %	413 M €
Sofina SA (Private Equity) 1.928 %	2,282,513	1.928 %	266 M €
bioMérieux SA Employee Stock Ownership Plan 0.7934 %	939,100	0.7934 %	109 M €
Financière de l'Échiquier SA 0.7766 %	919,188	0.7766 %	107 M €

List of BIOMÉRIEUX shareholders

Holdings: bioMérieux

Name	Equities	%	Valuation
OXFORD NANOPORE TECHNOLOGIES PLC 6.11%	59,062,832	6.11%	126 M $
BIOMÉRIEUX 0.36%	428,973	0.36%	50 M $

Company details: bioMérieux

bioMérieux SA

376, chemin de l'Orme

69280, Marcy l'Etoile

+33 4 78 87 20 00

http://www.biomerieux.com

Group companies: bioMérieux

Name	Category and Sector
bioMérieux CZ sro bioMérieux CZ sro Manufactures laboratory equipment
bioMérieux CZ sro bioMérieux CZ sro Manufactures laboratory equipment
bioMérieux China Ltd. (HongKong) bioMérieux China Ltd. (HongKong) Wholesales and distributes surgical and medical instruments
bioMérieux Asia Pacific Pte Ltd.
bioMérieux Asia Pacific Pte Ltd.

See all subsidiaries

Diagnostic & Testing Substances

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
BIOMÉRIEUX	+1.07%	-2.63%	-16.73%	-2.77%	13.12B
GUARDANT HEALTH, INC.	-0.29%	-7.09%	+136.55%	+275.24%	13.57B
CARIS LIFE SCIENCES, INC.	-0.63%	-4.44%	-	-	6.29B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-0.85%	+0.87%	-14.53%	-12.99%	6.13B
DIASORIN S.P.A.	-0.05%	+4.43%	-25.72%	-36.99%	4.79B
LANTHEUS HOLDINGS, INC.	+3.01%	+1.77%	-22.71%	+15.27%	4.32B
AUTOBIO DIAGNOSTICS CO., LTD.	-0.03%	+1.36%	-10.60%	-47.99%	3.02B
ANDON HEALTH CO., LTD.	-0.66%	+3.71%	+0.64%	-18.61%	2.58B
10X GENOMICS, INC.	+3.29%	-0.67%	+58.79%	-55.89%	2.35B
Average	+0.54%	-2.85%	+13.21%	+14.41%	6.24B
Weighted average by Cap.	+0.35%	-4.29%	+28.68%	+63.83%